Elminda, is an inspiring brain-tech company addressing one of the ultimate challenges - understanding the human brain, paving a path for better brain health.
In the endless quest for “better health” there are many methods of measuring every part of our bodies. But the brain is one area where real innovation is sorely needed. The inability to accurately measure brain function hinders the management of injuries like concussions, disorders like chronic pain and the discovery for effective therapies for Alzheimer's disease or depression. Importantly, it prevents us from taking ownership of our own brain’s health.
Elminda is breaking those barriers with BNA™ (Brain Network Analytics) technology, an electro-physiology based functional brain mapping, imaging and monitoring technology that finally allows medical professionals as well as patients and their families to SEE more, KNOW more and DO more, inspiring a revolutionary path to better brain health and creation of new standards for the assessment and treatment of brain related disorders.
Elminda has spent a decade pioneering a fusion of big data analytics, artificial intelligence and brain network analytics mapping that can quantify function and dysfunction, disease progression, and therapeutic effects in cases of neurological and psychiatric disorders such as depression or pain.
BNA™ was cleared by the FDA and CE Mark and is available for commercial and clinical use in the US, EU as well as in Israel. Elminda is a revenue stage company with a unique business model combining a medical device and high margin cloud-based Software as a Service (SaaS). The company employs a top team of employees with offices in both Herzeliya and Chicago.
The company is widely recognized for its innovative approach to neuroscience, ranking among Fast Company’s annual list of the World's most innovative companies and a World Economic Forum Technology Pioneer.
In the endless quest for “better health” there are many methods of measuring every part of our bodies. But the brain is one area where real innovation is sorely needed. The inability to accurately measure brain function hinders the management of injuries like concussions, disorders like chronic pain and the discovery for effective therapies for Alzheimer's disease or depression. Importantly, it prevents us from taking ownership of our own brain’s health.
Elminda is breaking those barriers with BNA™ (Brain Network Analytics) technology, an electro-physiology based functional brain mapping, imaging and monitoring technology that finally allows medical professionals as well as patients and their families to SEE more, KNOW more and DO more, inspiring a revolutionary path to better brain health and creation of new standards for the assessment and treatment of brain related disorders.
Elminda has spent a decade pioneering a fusion of big data analytics, artificial intelligence and brain network analytics mapping that can quantify function and dysfunction, disease progression, and therapeutic effects in cases of neurological and psychiatric disorders such as depression or pain.
BNA™ was cleared by the FDA and CE Mark and is available for commercial and clinical use in the US, EU as well as in Israel. Elminda is a revenue stage company with a unique business model combining a medical device and high margin cloud-based Software as a Service (SaaS). The company employs a top team of employees with offices in both Herzeliya and Chicago.
The company is widely recognized for its innovative approach to neuroscience, ranking among Fast Company’s annual list of the World's most innovative companies and a World Economic Forum Technology Pioneer.
Location: Israel, Tel Aviv District, Herzliya
Employees: 51-200
Total raised: $30M
Founded date: 2006
Investors 4
| Date | Name | Website |
| - | Connectivi... | connectivi... |
| - | WR Hambrec... | wrhambrech... |
| 12.11.2023 | Shanda Gro... | shanda.com |
| 12.03.2022 | WISE Ventu... | wiseventur... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.11.2015 | Series C | $30M | - |
Mentions in press and media 10
| Date | Title | Description |
| 26.01.2021 | Tel Aviv and Jerusalem ecosystem: beyond startups Strengths Weaknesses Technological spheres Accelerators and incubators What to expect in Tel Aviv and Jerusalem? | Tel Aviv and Jerusalem ecosystem: beyond startups |
| 26.01.2021 | Tel Aviv and Jerusalem ecosystem: beyond startups Strengths Weaknesses Technological spheres Accelerators and incubators What to expect in Tel Aviv and Jerusalem? | Tel Aviv and Jerusalem ecosystem: beyond startups |
| 26.01.2021 | Экосистема Тель-Авива и Иерусалима: не только стартапы | Экосистема Тель-Авива и Иерусалима: не только стартапы |
| 13.02.2020 | Interested in Investing in Early Stage Firms? OurCrowd Has a Long List, Reports 36 Exits to Date | OurCrowd is arguably the leading investment crowdfunding platform in the world. Based in Israel but listing offerings from companies around the world, OurCrowd has seen approximately $1.4 billion in committed funding since inception. Of the... |
| 19.06.2017 | Pro Football Hall of Famers Connect with Jerusalem's Innovation All-Stars | New England Patriots Chairman and CEO Robert Kraft Leads a Delegation of 18 Gold Jackets to Start-Up Nation [[{"fid":"75746","view_mode":"default","fields":{"format":"default... |
| 17.11.2015 | Daily funding roundup - November 17, 2015 | Earnest bagged $275M; Datto raised $75M; IIX Inc. secured $26M Skulpt, creator of a device for measuring body fat percentage and muscle quality, today announced that it had raised $4.1 million in a Series A funding round led by Nautilus Ven... |
| 16.11.2015 | ElMindA gets $30M for test that charts brain activity over time | A notable investor in this round is the Kraft Group, which owns the New England Patriots. Brain injuries plague football players, after all – which could make a monitoring tool like this one quite useful. Other investors include Shanda Grou... |
| 16.11.2015 | ElMindA Completes $28M Series C Financing Round | ElMindA Ltd., a Glenview IL-based developer of neuroscience-based technology for analyzing brain network functionality, completed a $28m Series C financing round. Backers included Shanda Group, The Kraft Group, Wexford Capital, WR Hambrecht... |
| 18.02.2015 | Рейтинг самых инновационных компаний мира по версии Fast Company: Кто опередил Apple, Tesla и Google | Издание Fast Company опубликовало ежегодный рейтинг самых инновационных компаний мира. В нем не нашлось места таким компаниям, как Uber, Facebook или Amazon, а Apple заняла только второе место. 1. Warby Parker «За построение великого интерн... |
| - | ElMindA gets $30M for test that charts brain activity over time | Chicago neuroscience startup ElMindA just closed out a $28 million Series C round for its noninvasive test that monitors brain functionality over a long period of time. It has particular use in studying, say, a person’s brain function befor... |